O'Brien T R, Busch M P, Donegan E, Ward J W, Wong L, Samson S M, Perkins H A, Altman R, Stoneburner R L, Holmberg S D
Division of HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia.
J Acquir Immune Defic Syndr (1988). 1994 Jul;7(7):705-10.
Using lookback procedures and other methods, we identified and then prospectively followed human immunodeficiency virus type 1 (HIV-1)-infected transfusion recipients and their sex partners to determine AIDS incidence and risks of heterosexual transmission of HIV-1. At enrollment, 7 of 32 (21.9%) female partners of male recipients were themselves infected with HIV-1, as compared with none of 14 male partners of female recipients (p = 0.08). No additional episodes of transmission were observed. The prevalence of advanced immunodeficiency at enrollment was similar in male and female recipients. Male recipients with advanced immunodeficiency (CD4+ lymphocyte count < or = 0.20 x 10(9)/L or a history of clinical AIDS) at enrollment were more likely to have infected their female partners (odds ratio = 7.9; p = 0.03) than men with neither condition. Similarly, AIDS-free survival, as estimated by the product-limit method, was lower among male transmitters than among male nontransmitters (p = 0.01). Transmission was not associated with frequency of unprotected vaginal intercourse. Our data suggest that HIV-1-infected men who develop immunodeficiency rapidly are more likely to infect their sex partners and that the greater efficiency of male-to-female HIV-1 transmission is not explained by a greater number of sexual contacts or more advanced immunodeficiency in index subjects.
通过回顾性研究方法及其他手段,我们识别出感染了1型人类免疫缺陷病毒(HIV-1)的输血受者及其性伴侣,并对其进行前瞻性随访,以确定艾滋病发病率及HIV-1异性传播的风险。在入组时,男性受者的32名女性伴侣中有7名(21.9%)自身感染了HIV-1,而女性受者的14名男性伴侣中无人感染(p = 0.08)。未观察到其他传播事件。入组时男性和女性受者中严重免疫缺陷的患病率相似。入组时患有严重免疫缺陷(CD4+淋巴细胞计数≤0.20×10⁹/L或有临床艾滋病病史)的男性受者比无上述情况的男性更有可能感染其女性伴侣(优势比 = 7.9;p = 0.03)。同样,通过乘积限法估算,男性传播者的无艾滋病生存期低于男性非传播者(p = 0.01)。传播与无保护阴道性交的频率无关。我们的数据表明,迅速发展为免疫缺陷的HIV-1感染男性更有可能感染其性伴侣,而且男性向女性传播HIV-1的更高效率不能用指数对象中更多的性接触次数或更严重的免疫缺陷来解释。